European Pharmaceutical Contractor (EPC) is designed to fill a unique position in pharmaceutical publishing. Providing a dedicated platform of communication and information for the international pharmaceutical contract market, it consists of a series of articles and case studies written by eminent figures in contractor groups and traditional multinational pharmaceutical companies.
Each quarterly edition examines areas of importance – both economic and technical – to contract research organisations, contract manufacturers, regulatory controllers, consultants and analysts. This enables regulatory bodies to link directly with policy-makers both in major contractor groups and pharmaceutical companies, and thereby convey regulatory information directly from the governing bodies, but also ensure debate between the policy-makers and consultancy groups.
Dr Graham Hughes,
Published quarterly in
September and December
10th Annual Cold Chain Distribution Conference and Exhibition
3-4 December 2015, Victoria Park Plaza, London, UK
This year’s Cold Chain
Distribution is the must attend event providing hours of
networking with your peers, where you will hear case studies, presentations and
round table discussions on the key issues surrounding the global healthcare
cold chain distribution process and logistic requirements for various
temperature-sensitive healthcare products.
Last year’s conference was sold out
– make sure you register as soon as possible to secure your seat!
Event website: http://www.coldchain-distribution.com/samedan.
First 20 pharma companies to register receive a
special £899 rate. Subject to availability. More info >>
To enhance the user experience of their corporate website, and to better
support their group companies (including SHL Medical, SHL Healthcare,
SHL Technologies and SHL Pharma), SHL Group are proud to introduce their
newest corporate website. More info >>
Clinical Trial Site Contracting: The Conservative, Progressive and Hybrid Models
For the last 20 years, pharmaceutical companies have turned to a variety of clinical outsourcing solutions to reduce costs and improve timelines, enabling them to focus on their core value of research and development. In today’s tightly competitive market, companies are constantly striving for ways to further cut costs and reduce study startup cycle times, while maintaining quality.
One of the key cost factors in global R&D spending, estimated at around $102 billion per Kalorama market research, is the cost of conducting clinical trials. CRO’s, which account for about 30% of the total R&D spending, have risen to the challenge of the clinical, technical and administrative management of these trials. But some pharmaceutical companies question how much control to relinquish to vendor partners, especially in the legal arena, due to potential ramifications.
More info >>